HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Rheumatology Network's Top 5: September 17, 2022

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending September 17, 2022.

Causal Link Found Between IBD and Psoriasis, Psoriatic Arthritis

Inflammatory bowel disease, including Crohn's disease and ulcerative colitis, frequently co-occurs with the immune-mediated inflammatory condition, psoriasis.

Patients with Autoimmune Disease at Greater Complications Risk Following Heart Attack

Investigators believe that coronary intervention, intensified medical therapy, and an aggressive risk factor optimization approach should be available to patients with rheumatic disease presenting with myocardial infarction whenever possible.

Long-Term Glucocorticoid Therapy in SLE and Infective Sequelae: A Faustian Pact

In SLE, higher doses of prednisolone and the use of immunosuppressive agents, such as cyclophosphamide, have been associated with higher rates of infective sequelae.

ACR Previews Updated Guidelines for Prevention, Treatment of Glucocorticoid-Induced Osteoporosis

The updated guidelines highlight new recommendations for medications, flexibility in drug selection, and sequential therapy.

Q&A: Determinants of Work, Social Participation in Patients With Psoriatic Arthritis

In this Q&A, Tamara van Hal, MD, discussed the findings of her study that evaluated the extent of work and activity impairment in patients with psoriatic arthritis and examined determinants associated with this impairment.